Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank7
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-45.32
↓ 117% vs avg
Percentile
P7
Near historical low
Streak
2 yr
Consecutive declineCompressed
Average
-20.87
Historical baseline
PeriodValueYoY Change
2025-45.32-221.6%
2024-14.09-21.7%
2023-11.57+31.3%
2022-16.84-190.7%
2021-5.79+31.8%
2020-8.49+49.2%
2019-16.71+67.1%
2018-50.83-40.9%
2017-36.08-1127.5%
2016-2.94-